Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study
Authors:
- Chenyang WangCWChenyang Wang
- Michael K. RooneyMRMichael K. Rooney
- Christopher Alvarez-BreckenridgeCAChristopher Alvarez-Breckenridge
- Thomas H. BeckhamTBThomas H. Beckham
- Caroline ChungCaroline Chung
- Brian S. DeBDBrian S. De
- Amol J. GhiaAGAmol J. Ghia
- David GrosshansDGDavid Grosshans
- Nazanin K. MajdNMNazanin K. Majd
- Mary F. McAleerMMMary F. McAleer
- Susan L. McGovernSMSusan L. McGovern
- Robert Y. NorthRNRobert Y. North
Open Access
Abstract
(1) Background: Myxopapillary ependymoma (MPE) is a rare tumor of the spine, typically slow-growing and low-grade. Optimal management strategies remain unclear due to limited evidence given the low incidence of the disease. (2) Methods: We analyzed data from 1197 patients with spinal MPE from the Surveillance, Epidemiology, and End Results (SEER) database (2000–2020). Patient demographics, treatment modalities, and survival outcomes were examined using statistical analyses. (3) Results: Most patients were White (89.9%) with a median age at diagnosis of 42 years. Surgical resection was performed in 95% of cases. The estimated 10-year overall survival was 91.4%. Younger age (hazard ratio (HR) = 1.09, p < 0.001) and receipt of surgery (HR = 0.43, p = 0.007) were associated with improved survival. Surprisingly, male sex was associated with worse survival (HR = 1.86, p = 0.008) and a younger age at diagnosis compared to females. (4) Conclusions: This study, the largest of its kind, underscores the importance of surgical resection in managing spinal MPE. The unexpected association between male sex and worse survival warrants further investigation into potential sex-specific pathophysiological factors influencing prognosis. Despite limitations, our findings contribute valuable insights for guiding clinical management strategies for spinal MPE.Keywords
This publication has 32 references indexed in Scilit:
- Clinical management and prognosis of spinal myxopapillary ependymoma: a single-institution cohort of 72 patientsEuropean Spine Journal, 2023
- Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patientsJournal of Neuro-Oncology, 2021
- Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) DatabaseJAMA Surgery, 2018
- Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomesJournal of Neuro-Oncology, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Myxopapillary ependymoma in children: A study of 11 cases and a comparison with the adult experiencePediatric Blood & Cancer, 2014
- The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer NetworkInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Long term outcomes following surgical resection of myxopapillary ependymomasNeurosurgical Review, 2009
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 casesCancer, 1985